JPMorgan kept its “neutral" recommendation on Salmat with a reduced price target of $1.28 a share down from $1.94.
“SLM is two years into a three-year transition. Sales and earnings for the company have declined over the past five years and we need to see evidence that the changes SLM has made to its business have been enough to arrest that decline.
Loading...
Elise Shaw writes on Markets specialising in Equity Markets, Commodities, Mining. Based in our Sydney newsroom, Elise has over 25 years experience as a finance and markets journalist and editor. Connect with Elise on Twitter.
